Stockreport

'Tumor agnostic' cancer drugs seen boosting wider genetic tests [Reuters]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF 'Tumor agnostic' cancer drugs seen boosting wider genetic tests CHICAGO New cancer drugs that target genetic mutations regardless of where the tumor is growing should e [Read more]